Clinical trial
Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee
NCT02116972 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT02116972 |
|---|---|
| Title | Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee |
| Official title | A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee |
| Intervention type | Drug |
| Interventions | FX006 32 mg, Placebo, FX006 16 mg |
| Enrollment | 310 |
| Start date | Apr 1, 2014 |
| Primary completion | Nov 1, 2015 |
| Completion | Nov 1, 2015 |
| First posted | Apr 17, 2014 |
| Last update posted | Jan 24, 2024 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: